# A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Given by Mouth and Into a Vein as an Injection

> **NCT03787186** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GLPG1690 film-coated tablets
- **DRUG:** [14C]-GLPG1690 solution for infusion
- **DRUG:** [14C]-GLPG1690 capsules

## Key facts

- **NCT ID:** NCT03787186
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-09
- **Primary completion:** 2019-01-17
- **Final completion:** 2019-01-17
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03787186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03787186, "A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Given by Mouth and Into a Vein as an Injection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03787186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*